HIV-associated tuberculosis

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Naidoo, Kogieleum ^a   Naidoo, Kasavan ^a   Padayatchi, Nesri ^a,b   Abdool Karim, Quarraisha ^a,b,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c Mailman School of Public Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ISONIAZID;

DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION CONTROL; INFECTION RISK; MIXED INFECTION; MORTALITY; MULTIDRUG RESISTANT TUBERCULOSIS; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; REPRODUCTIVE HEALTH; REVIEW; SCALE UP; SEXUAL HEALTH; TUBERCULOSIS;

EID: 77957874626     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/585919     Document Type: Review

References (86)

1. Zumla A., Mwaba P., Huggett J., Kapata N., Chanda D., Grange J., Reflections on the white plague The Lancet Infectious Diseases 2009 9 3 197 202
2. WHO, Global tuberculosis controlepidemiology, strategy, financing WHO Report 2009 Geneva, Switzerland
3. UNAIDS, 2008 Report on the Global AIDS Epidemic 2008 Geneva, Switzerland
4. Grange J., Adhikari M., Ahmed Y., Mwaba P., Dheda K., Hoelscher M., Zumla A., Tuberculosis in association with HIV/AIDS emerges as a major nonobstetric cause of maternal mortality in Sub-Saharan Africa International Journal of Gynecology and Obstetrics 2010 108 3 181 183
5. Khan M., Pillay T., Moodley J. M., Connolly C. A., Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa AIDS 2001 15 14 1857 1863
6. Ramogale M. R., Moodley J., Sebitloane M. H., HIV-associated maternal mortalityprimary causes of death at King Edward VIII Hospital, Durban South African Medical Journal 2007 97 5 363 366
7. Walters E., Cotton M. F., Rabie H., Simon H. S., Walters L. O., Marais B. J., Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy BMC Pediatrics 2008 8, article no. 1
8. Bhat G. J., Diwan V. K., Chintu C., Kabika M., Masona J., HIV, BCG and TB in children: a case control study in Lusaka, Zambia Journal of Tropical Pediatrics 1993 39 4 219 223
9. Zar H. J., Cotton M. F., Strauss S., Karpakis J., Hussey G., Schaaf S., Rabie H., Lombard C. J., Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial British Medical Journal 2007 334 7585 136 139
10. McIlleron H., Meintjes G., Burman W. J., Maartens G., Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome Journal of Infectious Diseases 2007 196 supplement 1 S63 S75
11. Samb B., Sow P. S., Kony S., Maynart-Badiane M., Diouf G., Cissokho S., B D., San M., Klotz F., Faye-Niang M. A., Mboup S., Ndoye I., Delaporte E., Hane A. A., Samb A., Coulaud J.-P., Coll-Seck A. M., Larouz B., Murray J. F., Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence International Journal of Tuberculosis and Lung Disease 1999 3 4 330 336
12. Greenberg S. D., Frager D., Suster B., Walker S., Stavropoulos C., Rothpearl A., Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance) Radiology 1994 193 1 115 119
13. Pepper T., Joseph P., Mwenya C., McKee G.-S., Haushalter A., Carter A., Warkentin J., Haas D. W., Sterling T. R., Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures International Journal of Tuberculosis and Lung Disease 2008 12 4 397 403
14. Perlman D. C., el-Sadr W. M., Nelson E. T., Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG) Clinical Infectious Diseases 1997 25 2 242 246
15. Bassett I. C. S., Wang B., Giddy J., Intensive TB Screening for HIV-infected Patients Ready to Start ART in Durban, South Africa: Limitations of WHO Guidelines. 2009, http://retroconference.org/2009/Abstracts/34392.htm
16. Edwards D. V. M., Bangani N., Dawson R., Baseline Screening for TB among Patients Enrolling in an ART Service in South Africa. 2009, http://www. retroconference.org/2009/abstracts/36271.htm
17. Dheda K., Shean K., Zumla A., Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study The Lancet 2010 375 9728 1798 1807
18. Dheda K., Davids V., Lenders L., Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples PLoS One 2010 5 3, article no. e9848
19. Roscigno G., Drug resistant TB and new diagnostics for people living with HIV: emerging results from FIND. IAS Conference; Catalysing HIV/TB research. 2009, http://www.stoptb.org/wg/tbhiv/assets/documents/DRUGRE1.PDF
20. Albert H., Bwanga F., Mukkada S., Nyesiga B., Ademun J. P., Lukyamuzi G., Haile M., Hoffner S., Joloba M., O'Brien R., Rapid screening of MDR-TB using molecular line probe assay is feasible in Uganda BMC Infectious Diseases 2010 10, article no. 41
21. Migliori G. B., Matteelli A., Cirillo D., Pai M., Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current standards and challenges Canadian Journal of Infectious Diseases and Medical Microbiology 2008 19 2 169 172 (Pubitemid 351754183)
22. Helb D., Jones M., Story E., Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology Journal of Clinical Microbiology 2010 48 1 229 237
23. Moore D. A. J., Evans C. A. W., Gilman R. H., Caviedes L., Coronel J., Vivar A., Sanchez E., Piedo Y., Saravia J. C., Salazar C., Oberhelman R., Hollm-Delgado M.-G., LaChira D., Escombe A. R., Friedland J. S., Microscopic-observation drug-susceptibility assay for the diagnosis of TB New England Journal of Medicine 2006 355 15 1539 1550
24. Scaaf H., Zumla A., Chapter 19: immune-based tests for tuberculosis Tuberculosis: A comprehensive Clinical Reference 2009 179 196
25. Mutetwa R., Boehme C., Dimairo M., Bandason T., Munyati S. S., Mangwanya D., Mungofa S., Butterworth A. E., Mason P. R., Corbett E. L., Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients International Journal of Tuberculosis and Lung Disease 2009 13 10 1253 1259
26. Reid M. J., Shah N. S., Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings The Lancet Infectious Diseases 2009 9 3 173 184
27. Howard A. A., El-Sadr W.M., Integration of tuberculosis and HIV services in sub-Saharan Africa: lessons learned Clinical Infectious Diseases 2010 50 supplement 3 S238 S244
28. WHO, UNAIDS, Guidance on Provider-Initiated HIV Testing and Counselling in Health Facilities 2007 Geneva, Switzerland
29. DOH, RSA, Provinces launch their HIV Counselling and Testing (HCT) campaigns today. 2010, http://www.info.gov.za/speeches/2010/10043011151001.htm
30. Padayatchi N., Unpublished data. CAPRISA, UKZN, South Africa, 2010
31. WHO, Interim policy on collaborative TB/HIV activities. Stop TB Department and Department of HIV/AIDS, World Health Organization, Geneva, Switzerland, 2004
32. WHO, Global Tuberculosis Control: Surveillance, Planning, Financing 2008 Geneva, Switzerland World Health Organisation
33. Abdool Karim S. S., Naidoo K., Grobler A., Padayatchi N., Baxter C., Gray A., Gengiah T., Nair G., Bamber S., Singh A., Khan M., Pienaar J., El-Sadr W., Friedland G., Abdool Karim Q., Timing of initiation of antiretroviral drugs during tuberculosis therapy New England Journal of Medicine 2010 362 8 697 706
34. Gandhi N. R., Shah N. S., Andrews J. R., Vella V., Moll A. P., Scott M., Weissman D., Marra C., Lalloo U. G., Friedland G. H., HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality American Journal of Respiratory and Critical Care Medicine 2010 181 1 80 86
35. Wells C. D., Cegielski J. P., Nelson L. J., Laserson K. F., Holtz T. H., Finlay A., Castro K. G., Weyer K., HIV infection and multidrug-resistant tuberculosisthe perfect storm Journal of Infectious Diseases 2007 196 supplement 1 S86 S107
36. O'Donnell M. R., Padayatchi N., Master I., Osburn G., Horsburgh C. R., Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa International Journal of Tuberculosis and Lung Disease 2009 13 7 855 861
37. Eshun-Wilson I., Havers F., Nachega J. B., Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings Journal of the International Association of Physicians in AIDS 2010 9 2 104 108
38. French M. A., Price P., Stone S. F., Immune restoration disease after antiretroviral therapy AIDS 2004 18 12 1615 1627
39. Lawn S. D., Bekker L.-G., Miller R. F., Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals Lancet Infectious Diseases 2005 5 6 361 373
40. Meintjes G., Lawn S. D., Scano F., Maartens G., French M. A., Worodria W., Elliott J. H., Murdoch D., Wilkinson R. J., Seyler C., John L., van der Loeff M. S., Reiss P., Lynen L., Janoff E. N., Gilks C., Colebunders R., Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings The Lancet Infectious Diseases 2008 8 8 516 523
41. Shelburne S. A. III, Hamill R. J., The immune reconstitution inflammatroy syndrome AIDS Reviews 2003 5 2 67 79
42. Breton G., Duval X., Estellat C., Poaletti X., Bonnet D., Mvondo D. M., Longuet P., Leport C., Vild J.-L., Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy Clinical Infectious Diseases 2004 39 11 1709 1712
43. Dhasmana D. J., Dheda K., Ravn P., Wilkinson R. J., Meintjes G., Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management Drugs 2008 68 2 191 208
44. Kumarasamy N., Chaguturu S., Mayer K. H., Solomon S., Yepthomi H. T., Balakrishnan P., Flanigan T. P., Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India Journal of Acquired Immune Deficiency Syndromes 2004 37 5 1574 1576
45. Narita M., Ashkin D., Hollender E. S., Pitchenik A. E., Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with aids American Journal of Respiratory and Critical Care Medicine 1998 158 1 157 161
46. Breen R. A. M., Smith C. J., Cropley I., Johnson M. A., Lipman M. C. I., Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS 2005 19 11 1201 1206
47. Dautremer J., Pacanowski J., Girard P.-M., Lalande V., Sivignon F., Meynard J.-L., A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis AIDS 2007 21 3 381 382
48. John L., Baalwa J., Kalimugogo P., Nabankema E., Castelnuovo B., Muhindo G., Colebunders R., Kambugu A., Response to does immune reconstitution promote active tuberculosis in patients receiving highly active antiretroviral therapy? AIDS 2005 19 17 2049 2050
49. Crowe S. M., Carlin J. B., Stewart K. I., Lucas C. R., Hoy J. F., Predictive value of CD4 lymphocyte number for the development of opportunistic infections and malignancies in HIV-infected persons Journal of Acquired Immune Deficiency Syndromes 1991 4 8 770 776
50. Muller M., Wandel S., Colebunders R., Attia S., Furrer H., Egger M., Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis The Lancet Infectious Diseases 2010 10 4 251 261
51. Lawn S. D., Myer L., Bekker L.-G., Wood R., Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa AIDS 2007 21 3 335 341
52. Walker A. S., Ford D., Gilks C. F., Munderi P., Ssali F., Reid A., Katabira E., Grosskurth H., Mugyenyi P., Hakim J., Darbyshire J. H., Gibb D. M., Babiker A. G., Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort The Lancet 2010 375 9722 1278 1286
53. Foster S., Godfrey-Faussett P., Porter J., Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia AIDS 1997 11 7 919 925
54. Golub J. E., Pronyk P., Mohapi L., Thsabangu N., Moshabela M., Struthers H., Gray G. E., Mclntyre J. A., Chaisson R. E., Martinson N. A., Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort AIDS 2009 23 5 631 636
55. Golub J. E., Saraceni V., Cavalcante S. C., Pacheco A. G., Moulton L. H., King B. S., Efron A., Moore R. D., Chaisson R. E., Durovni B., The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil AIDS 2007 21 11 1441 1448
56. Woldehanna S., Volmink J., Treatment of latent tuberculosis infection in HIV infected persons Cochrane Database of Systematic Reviews (Online) 2004 1, article no. CD000171
57. Churchyard G. J., Scano F., Grant A. D., Chaisson R. E., Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities Journal of Infectious Diseases 2007 196 supplement 1 S52 S62
58. Lucas S. B., Hounnou A., Peacock C., Beaumel A., Djomand G., N'Gbichi J.-M., Yeboue K., Honde M., Diomande M., Giordano C., Doorly R., Brattegaard K., Kestens L., Smithwick R., Kadio A., Ezani N., Yapi A., De Cock K. M., The mortality and pathology of HIV infection in a West African city AIDS 1993 7 12 1569 1579
59. IUATLD. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International union against tuberculosis committee on prophylaxis Bulletin of the World Health Organization 1982 60 4 555 564
60. De Pinho A. M. F., Santoro-Lopes G., Harrison L. H., Schechter M., Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil AIDS 2001 15 16 2129 2135
61. Mosimaneotsile B., Mathoma A., Chengeta B., Nyirenda S., Agizew T. B., Tedla Z., Motsamai O. I., Kilmarx P. H., Wells C. D., Samandari T., Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a botswana experience, 20042006 Journal of Acquired Immune Deficiency Syndromes 2010 54 1 71 77
62. Akolo C., Adetifa I., Shepperd S., Volmink J., Treatment of latent tuberculosis infection in HIV infected persons (Review) The Cochrane Collaboration 2010 1, article no. CD000171
63. At-Khaled N., Alarcon E., Bissell K., Boillot F., Caminero J. A., Chiang C.-Y., Clevenbergh P., Dlodlo R., Enarson D. A., Enarson P., Ferroussier O., Fujiwara P. I., Harries A. D., Heldal E., Hinderaker S. G., Kim S. J., Lienhardt C., Rieder H. L., Rusen I. D., Trbucq A., Van Deun A., Wilson N., Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues International Journal of Tuberculosis and Lung Disease 2009 13 8 927 935
64. Preventive therapy against tuberculosis in people living with HIV Weekly Epidemiological Record 1999 74 46 385 398
65. Mwinga A., Hosp M., Godfrey-Faussett P., Quigley M., Mwaba P., Mugala B. N., Nyirenda O., Luo N., Pobee J., Elliott A. M., McAdam K. P. W. J., Porter J. D. H., Twice weekly tuberculosis preventive therapy in HIV infection in Zambia AIDS 1998 12 18 2447 2457
66. WHO, Guidance for national TB programmes (NTPs) on managing TB in children. Geneva, Switzerland, 2006, http://whqlibdoc.who.int/hq/2006/ WHOHTMTB2006.371eng.pdf
67. WHO, UNAIDS, Policy statement on preventive therapy against tuberculosis in people living with HIV Report of a meeting held in Geneva. Geneva, Switzerland, 1998
68. Korenromp E. L., Scano F., Williams B. G., Dye C., Nunn P., Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review Clinical Infectious Diseases 2003 37 1 101 112
69. Maher D., Harries A., Getahun H., Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies Tropical Medicine and International Health 2005 10 8 734 742
70. Mallory K. F., Churchyard G. J., Kleinschmidt I., De Cock K. M., Corbett E. L., The impact of HIV infection on recurrence of tuberculosis in South African gold miners International Journal of Tuberculosis and Lung Disease 2000 4 5 455 462
71. Onyebujoh P. C., Ribeiro I., Whalen C. C., Treatment options for HIV-associated tuberculosis Journal of Infectious Diseases 2007 196 supplement 1 S35 S45
72. Sonnenberg P., Murray J., Glynn J. R., Shearer S., Kambashi B., Godfrey-Faussett P., HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers Lancet 2001 358 9294 1687 1693
73. Fitzgerald D. W., Desvarieux M., Severe P., Joseph P., Johnson W. D. Jr., Pape J. W., Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial Lancet 2000 356 9240 1470 1474
74. Perriens J. H., St. Louis M. E., Mukadi Y. B., Brown C., Prignot J., Pouthier F., Portaels F., Willame J.-C., Mandala J. K., Kaboto M., Ryder R. W., Roscigno G., Piot P., Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months New England Journal of Medicine 1995 332 12 779 784
75. Hanson D. L., Chu S. Y., Farizo K. M., Ward J. W., Stetler H. C., Sorvillo F., Buskin S. E., Shaner K. L., Mokotoff E., Davidson A., Troxler S. H., Phelps A. F., Coronado V. G., Distribution of CD4 + T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses Archives of Internal Medicine 1995 155 14 1537 1542
76. Kirk O., Mocroft A., Pedersen C., Proenca R., Brettle R. P., Barton S. E., Sudre P., Phillips A. N., Lundgren J. D., Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy American Journal of Respiratory and Critical Care Medicine 2000 162 3 865 872
77. Lawn S. D., Bekker L.-G., Wood R., How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control AIDS 2005 19 11 1113 1124
78. WHO, WHO policy on TB infection control in health-care facilities, congregate settings and households. Geneva, Switzerland, 2009
79. Bock N. N., Jensen P. A., Miller B., Nardell E., Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment Journal of Infectious Diseases 2007 196 supplement 1 S108 S113
80. Escombe A. R., Moore D. A. J., Gilman R. H., Navincopa M., Ticona E., Mitchell B., Noakes C., Martinez C., Sheen P., Ramirez R., Quino W., Gonzalez A., Friedland J. S., Evans C. A., Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmissio PLoS Medicine 2009 6 3, article no. e43
81. Escombe A. R., Oeser C. C., Gilman R. H., Navincopa M., Ticona E., Pan W., Martnez C., Chacaltana J., Rodrguez R., Moore D. A. J., Friedland J. S., Evans C. A., Natural ventilation for the prevention of airborne contagion PLoS Medicine 2007 4 2, article no. e68
82. First M. W., Weker R. A., Yasui S., Nardell E. A., Monitoring human exposures to upper-room germicidal ultraviolet irradiation Journal of Occupational and Environmental Hygiene 2005 2 5 285 292
83. Francis J., Curry National Tuberculosis Center. Tuberculosis infection control: A practical manual for preventing TB. 2007, http://www. nationaltbcenter.edu/TBIC/docs/06SputumInduction.pdf
84. Humphreys H., Control and prevention of healthcare-associated tuberculosis: the role of respiratory isolation and personal respiratory protection Journal of Hospital Infection 2007 66 1 1 5
85. Gamage B., Moore D., Copes R., Yassi A., Bryce E., Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature American Journal of Infection Control 2005 33 2 88 96
86. Moore D., Gamage B., Bryce E., Copes R., Yassi A., Protecting health care workers from SARS and other respiratory pathogens: organizational and individual factors that affect adherence to infection control guidelines American Journal of Infection Control 2005 33 2 114 121